References
- Brownlee S, Chalkidou K, Doust J, et al. Evidence for overuse of medical services around the world. Lancet. 2017;390(10090):156–168.
- Chassin MR, Galvin RW. The urgent need to improve health care quality. Institute of Medicine National Roundtable on Health Care Quality. JAMA. 1998;280(11):1000–1005.
- Naugler C, Wyonch R. What the doctor ordered: improving the use and value of laboratory testing. C.D. Howe Institute Commentary No. 533; 2019. Available from: https://www.cdhowe.org/public-policy-research/what-doctor-ordered-improving-use-and-value-laboratory-testing
- Unnecessary Care in Canada. Choosing Wisely Canada. Canadian Institute for Health Information; 2017. Available from: https://www.cihi.ca/en/unnecessary-care-in-canada
- Thomas RE, Croal BL, Ramsay C, et al. Effect of enhanced feedback and brief educational reminder messages on laboratory test requesting in primary care: a cluster randomised trial. Lancet. 2006;367(9527):1990–1996.
- Cadamuro J, Gaksch M, Wiedemann H, et al. Are laboratory tests always needed? Frequency and causes of laboratory overuse in a hospital setting. Clin Biochem. 2018;54:85–91.
- Health Industry Distributors Association, (HIDA). 2019 US laboratory market report; 2019. Available from: https://www.researchandmarkets.com/reports/4803970/2019-us-laboratory-market-report
- Global Clinical Laboratory Services Industry. Global industry analysts; 2020. Available from: https://www.reportlinker.com/p04707129/Global-Clinical-Laboratory-Services-Services.html?utm_source=GNW
- Bogavac-Stanojevic N, Jelic-Ivanovic Z. The cost-effective laboratory: implementation of economic evaluation of laboratory testing. J Med Biochem. 2017;36(3):238–242.
- About Choosing Wisely Canada. Choosing Wisely Canada. 2021. Available from: https://choosingwiselycanada.org/about/
- Greenberg J, Green JB. Over-testing: why more is not better. Am J Med. 2014;127(5):362–363.
- Born K, Kool T, Levinson W. Reducing overuse in healthcare: advancing choosing wisely. BMJ. 2019;367:l6317.
- Moore RE. An historical perspective on the clinical diagnostic laboratory. In: Coleman W, Tsongalis G, editors. Molecular diagnostics: for the clinical laboratorian. 2nd ed. Totowa (NJ): Humana Press; 2006. p. 3–20.
- The Nobel Prize in Physiology or Medicine 1984. The Nobel Prize; 1984. Available from: https://www.nobelprize.org/prizes/medicine/1984/summary/
- Neary NM, King KS, Pacak K. Drugs and pheochromocytoma–don't be fooled by every elevated metanephrine. N Engl J Med. 2011;364(23):2268–2270.
- Favaloro EJ, Lippi GG. Preanalytical issues that may cause misdiagnosis in haemophilia and von Willebrand disease. Haemophilia. 2018;24(2):198–210.
- Lippi G, Betsou F, Cadamuro J, et al. Preanalytical challenges - time for solutions. Clin Chem Lab Med. 2019;57(7):974–981.
- Naugler C, Chin A, Thomas R, et al. Implementation of an intervention to reduce population-based screening for vitamin D deficiency: a cross-sectional study. CMAJ Open. 2017;5(1):E36–9.
- Gilmour JA, Weisman A, Orlov S, et al. Promoting resource stewardship: reducing inappropriate free thyroid hormone testing. J Eval Clin Pract. 2017;23(3):670–675.
- Taher J, Beriault DR, Yip D, et al. Reducing free thyroid hormone testing through multiple plan-do-study-act cycles. Clin Biochem. 2020;81:41–46.
- Institute of Medicine. Clinical practice guidelines we can trust. Washington (DC): The National Academies Press; 2011.
- Facts and Figures. Choosing Wisely. 2021. Available from: https://www.choosingwisely.org/our-mission/facts-and-figures/
- Recommendations. Choosing Wisely Canada. 2021. Available from: https://choosingwiselycanada.org/recommendations/
- Patient-centered Laboratory Utilization Guidance Services (PLUGS). Seattle Children's Hospital. 2021. Available from: https://www.schplugs.org/
- Haynes SL, Torella F. The role of hospital transfusion committees in blood product conservation. Transfus Med Rev. 2004;18(2):93–104.
- Warren JS. Laboratory test utilization program: structure and impact in a large academic medical center. Am J Clin Pathol. 2013;139(3):289–297.
- Mohammed E, Naugler C, Far B. Emerging business intelligence framework for a clinical laboratory through big data analytics. Chapter 32. In: Arabnia HR, Tran QN, editors. Emerging trends in computational biology, bioinformatics, and systems biology. New York (NY): Elsevier; 2015. p. 577.
- Naugler CT, Guo M. Mean abnormal result rate: proof of concept of a new metric for benchmarking selectivity in laboratory test ordering. Am J Clin Pathol. 2016;145(4):568–573.
- Brack AP, Guo M, Ma I, et al. Use of the mean abnormal result rate (MARR) to gauge changes in family physicians' selectivity of laboratory test ordering, 2010–2015. Am J Clin Pathol. 2017;148(5):436–440.
- Ismail O, Chin-Yee I, Gob A, et al. Reducing red blood cell folate testing: a case study in utilisation management. BMJ Open Qual. 2019;8(1):e000531.
- National minimum retesting intervals in pathology: a final report detailing consensus recommendations for minimum retesting intervals for use in pathology. The Royal College of Pathologists, The Association for Clinical Biochemistry and Laboratory Medicine, and The Institute of Biomedical Science; 2018. Available from https://www.rcpath.org/uploads/assets/253e8950-3721-4aa2-8ddd4bd94f73040e/g147_minretestingintervalsinpathology_dec15.pdf
- Chami N, Simons JE, Sweetman A, et al. Rates of inappropriate laboratory test utilization in Ontario. Clin Biochem. 2017;50(15):822–827.
- Kandalam V, Lau CK, Guo M, et al. Inappropriate repeat testing of complete blood count (CBC) and electrolyte panels in inpatients from Alberta, Canada. Clin Biochem. 2020;77:32–35.
- 3, Silverstein W, Weinerman A, Wang R, et al. Use of routine bloodwork on general internal medicine inpatients: a retrospective cohort study. Blood. 2019;134(Supplement_1):56–56.
- Moynihan R, Henry D, Moons KGM. Using evidence to combat overdiagnosis and overtreatment: evaluating treatments, tests, and disease definitions in the time of too much. PLoS Med. 2014;11(7):e1001655.
- Welch HG, Albertsen PC. Prostate cancer diagnosis and treatment after the introduction of prostate-specific antigen screening: 1986–2005. J Natl Cancer Inst. 2009;101(19):1325–1329.
- Welch HG, Albertsen PC. Reconsidering prostate cancer mortality - the future of PSA screening. N Engl J Med. 2020;382(16):1557–1563.
- Kurian AW, Li Y, Hamilton AS, et al. Gaps in incorporating germline genetic testing into treatment decision-making for early-stage breast cancer. J Clin Oncol. 2017;35(20):2232–2239.
- Li A, Hicks LK, Fan E. Things we do for no reason: HIT testing in low probability patients. J Hosp Med. 2019;14(6):374–376.
- Mold JW, Stein HF. The cascade effect in the clinical care of patients. N Engl J Med. 1986;314(8):512–514.
- Lauzier S, Lauzier S, Maunsell E, et al. Psychological distress and physical health in the year after diagnosis of DCIS or invasive breast cancer. Breast Cancer Res Treat. 2010;120(3):685–691.
- Kirkland KB. Taking off the gloves: toward a less dogmatic approach to the use of contact isolation. Clin Infect Dis. 2009;48(6):766–771.
- Nelson HD, Pappas M, Cantor A, et al. Harms of breast cancer screening: systematic review to update the 2009 U.S. preventive services task force recommendation. Ann Intern Med. 2016;164(4):256–267.
- Whiting D, Croker R, Watson J, et al. Optimising laboratory monitoring of chronic conditions in primary care: a quality improvement framework. BMJ Open Qual. 2019;8(1):e000349.
- Vermeer NCA, Valk MJM, Snijders HS, et al. Psychological distress and quality of life following positive fecal occult blood testing in colorectal cancer screening. Psycho‐Oncology. 2020;29(6):1084–1091.
- Sullivan DR, Golden SE, Ganzini L, et al. 'I still don't know diddly': a longitudinal qualitative study of patients' knowledge and distress while undergoing evaluation of incidental pulmonary nodules. NPJ Prim Care Respir Med. 2015;25(1):15028.
- Schmidt CO, Hegenscheid K, Erdmann P, et al. Psychosocial consequences and severity of disclosed incidental findings from whole-body MRI in a general population study. Eur Radiol. 2013;23(5):1343–1351.
- Bélisle-Pipon J, Vayena E, Green RC, et al. Genetic testing, insurance discrimination and medical research: what the United States can learn from peer countries. Nat Med. 2019;25(8):1198–1204.
- Himmelstein DU, Thorne D, Warren E, et al. Medical bankruptcy in the united states, 2007: results of a national study. Am J Med. 2009;122(8):741–746.
- Himmelstein DU, Lawless RM, Thorne D, et al. Medical bankruptcy: still common despite the affordable care act. Am J Public Health. 2019;109(3):431–433.
- Emanuel EJ, Fuchs VR. The perfect storm of overutilization. JAMA. 2008;299(23):2789–2791.
- Keyhani S, Falk R, Howell EA, et al. Overuse and systems of care: a systematic review. Med Care. 2013;51(6):503–508.
- Gosden T, Forland F, Kristiansen I, et al. Capitation, salary, fee-for-service and mixed systems of payment: effects on the behaviour of primary care physicians. Cochrane Database System Rev. 2000;3(10):1–24.
- Hicks LK. Reframing overuse in health care: time to focus on the harms. J Oncol Pract. 2015;11(3):168–170.
- Institute of Medicine. Best care at lower cost: the path to continuously learning health care in America. Washington (DC): The National Academies Press; 2013.
- Vrijsen BEL, Naaktgeboren CA, Vos LM, et al. Inappropriate laboratory testing in internal medicine inpatients: prevalence, causes and interventions. Ann Med Surg (Lond). 2020;51:48–53.
- Greenland P, Alpert JS, Beller GA, et al. 2010 ACCF/AHA guideline for assessment of cardiovascular risk in asymptomatic adults: executive summary: a report of the american college of cardiology foundation/American Heart Association task force on practice guidelines. Circulation. 2010;122(25):2748–2764.
- Hickey SE, Curry CJ, Toriello HV. ACMG practice guideline: lack of evidence for MTHFR polymorphism testing. Genet Med. 2013;15(2):153–156.
- Parkhurst E, Calonico E, Noh G. Medical decision support to reduce unwarranted methylene tetrahydrofolate reductase (MTHFR) genetic testing. J Med Syst. 2020;44(9):152.
- Institute of Medicine. Crossing the quality chasm: a new health system for the 21st Century. Washington (DC): The National Academies Press; 2001.
- Nolan TW. Execution of strategic improvement initiatives to produce system-level results. IHI Innovation Series white paper. Cambridge (MA): Institute for Healthcare Improvement; 2007. Available from: http://www.ihi.org/resources/Pages/IHIWhitePapers/ExecutionofStrategicImprovementInitiativesWhitePaper.aspx
- Mukerji G, Halperin I, Segal P, et al. Beginning a diabetes quality improvement project. Can J Diabetes. 2019;43(4):234–240.
- Brugha R, Varvasovszky Z. Stakeholder analysis: a review. Health Policy Plan. 2000;15(3):239–246.
- Institute for Healthcare Improvement. Science of improvement: forming the team. 2021. Available from: http://www.ihi.org/resources/Pages/HowtoImprove/ScienceofImprovementFormingtheTeam.aspx
- Trainees Improving Patient Safety through Quality Improvement (TIPSQI). Defining the problem - SMART aims. 2021. Available from: https://tipsqi.co.uk/guide-5c/
- Institute for Healthcare Improvement. Science of improvement: establishing measures [Internet]; 2020 [cited 2020 Nov 30]. Available from: http://www.ihi.org/resources/Pages/HowtoImprove/ScienceofImprovementEstablishingMeasures.aspx
- Institute for Healthcare Improvement. Cause and effect diagram. 2021. Available from: http://www.ihi.org/resources/Pages/Tools/CauseandEffectDiagram.aspx
- Institute for Safe Medication Practices (ISMP). Medication error prevention “toolbox. ISMP Med Saf Alert. 1999;11(4):1–2.
- Bread P, Hoffman C, Ste-Marie M. Canadian incident analysis framework - key features of effective recommended actions. Incident analysis collaborating parties; 2012. Available from: https://www.patientsafetyinstitute.ca/en/toolsResources/PatientSafetyIncidentManagementToolkit/Documents/CIAF%20Key%20Features%20-%20Analysis%20Process.pdf
- Perla RJ, Provost LP, Murray SK. The run chart: a simple analytical tool for learning from variation in healthcare processes. BMJ Qual Saf. 2011;20(1):46–51.
- Thor J, Lundberg J, Ask J, et al. Application of statistical process control in healthcare improvement: systematic review. Qual Saf Health Care. 2007;16(5):387–399.
- Berwick DM. Disseminating innovations in health care. JAMA. 2003;289(15):1969–1975.
- Baron JM, Dighe AS. The role of informatics and decision support in utilization management. Clin Chim Acta. 2014;427:196–201.
- Kim JY, Dzik WH, Dighe AS, et al. Utilization management in a large urban academic medical center: a 10-year experience. Am J Clin Pathol. 2011;135(1):108–118.
- Ash JS, Sittig DF, Campbell EM, et al. Some unintended consequences of clinical decision support systems. AMIA Annu Symp Proc. 2007;2007:26–30.
- Shojania KG, Jennings A, Mayhew A, et al. Effect of point-of-care computer reminders on physician behaviour: a systematic review. CMAJ. 2010;182(5):E216–25.
- Kobewka DM, Ronksley PE, McKay JA, et al. Influence of educational, audit and feedback, system based, and incentive and penalty interventions to reduce laboratory test utilization: a systematic review. Clin Chem Lab Med. 2015;53(2):157–183.
- Ivers N, Jamtvedt G, Flottorp S, et al. Audit and feedback: effects on professional practice and healthcare outcomes. Cochrane Database System Rev. 2012;(6):CD000259.
- Levi O, Chan M, Bodley T, et al. Reducing repetitive and reflexive diagnostic phlebotomy in an intensive care unit: a quality improvement project. Blood. 2019;134:3406.
- Fillée C, Beguin C, Habimana L, et al. How to optimize the prescription of laboratory tests? Success and failures in an academic hospital. Scand J Clin Lab Invest. 2018;78(3):197–203.
- Fralick M, Hicks LK, Chaudhry H, et al. REDucing unnecessary coagulation testing in the emergency department (REDUCED). BMJ Qual Improv Report. 2017;6(1):u221651.w8161.
- Leis B, Frost A, Bryce R, et al. Standard admission order sets promote ordering of unnecessary investigations: a quasi-randomised evaluation in a simulated setting. BMJ Qual Saf. 2017;26(11):938–940.
- Crider KS, Bailey LB, Berry RJ. Folic acid food fortification-its history, effect, concerns, and future directions. Nutrients. 2011;3(3):370–384.
- Strauss R, Cressman A, Cheung M, et al. Major reductions in unnecessary aspartate aminotransferase and blood urea nitrogen tests with a quality improvement initiative. BMJ Qual Saf. 2019;28(10):809–816.
- Mohammed-Ali Z, Brinc D, Kulasingam V, et al. Defining appropriate utilization of AST testing. Clin Biochem. 2020;79:75–77.
- Ivica J, Hill S. The potential of reducing AST testing in hospital settings. Clin Biochem. 2019;64:57–59.
- Taher J, Brinc D, Gilmour JA, et al. Validating thyroid-stimulating hormone (TSH) reflexive testing cutpoints in a tertiary care institution. Clin Chem Lab Med. 2019;58(1):11–13.
- Zhang G, Hu Z. Conjugated bilirubin as a reflex test for increased total bilirubin in apparently healthy population. J Clin Lab Anal. 2018;32(2):e22233.
- Rubio-Tapia A, Hill ID, Kelly CP, et al. ACG clinical guidelines: diagnosis and management of celiac disease. Am J Gastroenterol. 2013;108(5):656–676.
- Husby S, Murray JA, Katzka DA. AGA clinical practice update on diagnosis and monitoring of celiac disease-changing utility of serology and histologic measures: expert review. Gastroenterology. 2019;156(4):885–889.
- Sezgin G, Li L, Wilson R, et al. Laboratory test utilization and repeat testing for inpatients of age 80 and over in Australia: a retrospective observational study. J Appl Lab Med. 2019;4(2):143–151.
- Janssens PMW, Wasser G. Managing laboratory test ordering through test frequency filtering. Clin Chem Lab Med. 2013;51(6):1207–1215.